Literature DB >> 27720719

History of antimicrobial drug discovery: Major classes and health impact.

Rustam Aminov1.   

Abstract

The introduction of antibiotics into clinical practice revolutionized the treatment and management of infectious diseases. Before the introduction of antibiotics, these diseases were the leading cause of morbidity and mortality in human populations. This review presents a brief history of discovery of the main antimicrobial classes (arsphenamines, β-lactams, sulphonamides, polypeptides, aminoglycosides, tetracyclines, amphenicols, lipopeptides, macrolides, oxazolidinones, glycopeptides, streptogramins, ansamycins, quinolones, and lincosamides) that have changed the landscape of contemporary medicine. Given within a historical timeline context, the review discusses how the introduction of certain antimicrobial classes affected the morbidity and mortality rates due to bacterial infectious diseases in human populations. Problems of resistance to antibiotics of different classes are also extensively discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial drug discovery; History

Mesh:

Substances:

Year:  2016        PMID: 27720719     DOI: 10.1016/j.bcp.2016.10.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  50 in total

1.  Microbial Metabolomics: From Methods to Translational Applications.

Authors:  Rui Guo; Xialin Luo; Xu Xin; Lian Liu; Xijun Wang; Haitao Lu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Authors:  Thomas M Wood; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

Review 3.  Underscoring interstrain variability and the impact of growth conditions on associated antimicrobial susceptibilities in preclinical testing of novel antimicrobial drugs.

Authors:  David A Sanchez; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2018-12-06       Impact factor: 7.624

4.  Modelling the antimicrobial pharmacodynamics for bacterial strains with versus without acquired resistance to fluoroquinolones or cephalosporins.

Authors:  Jessica R Salas; Tara Gaire; Victoria Quichocho; Emily Nicholson; Victoriya V Volkova
Journal:  J Glob Antimicrob Resist       Date:  2021-12-16       Impact factor: 4.035

Review 5.  Bacteriophages and their potential for treatment of gastrointestinal diseases.

Authors:  Yi Duan; Ry Young; Bernd Schnabl
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-15       Impact factor: 46.802

6.  Kinetic, equilibrium, and thermodynamic performance of sulfonamides adsorption onto graphene.

Authors:  Shuting Zhuang; Xin Zhu; Jianlong Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-30       Impact factor: 4.223

7.  Genus-Wide Assessment of Antibiotic Resistance in Lactobacillus spp.

Authors:  Ilenia Campedelli; Harsh Mathur; Elisa Salvetti; Siobhán Clarke; Mary C Rea; Sandra Torriani; R Paul Ross; Colin Hill; Paul W O'Toole
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

8.  Macrolide antibiotics in the treatment of chronic rhinosinusitis: evidence from a meta-analysis.

Authors:  Shen Shen; Hongfei Lou; Chengshuo Wang; Luo Zhang
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 9.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

10.  Potent Antimicrobial and Antibiofilm Activities of Feleucin-K3 Analogs Modified by α-(4-Pentenyl)-Ala against Multidrug-Resistant Bacteria.

Authors:  Xiaomin Guo; Tiantian Yan; Jing Rao; Xin Yue; Xiong Pei; Jiahui Deng; Wangsheng Sun; Wenle Yang; Bangzhi Zhang; Junqiu Xie
Journal:  Biomolecules       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.